Metabolic vulnerabilities in CML & the impact of TKIs on glucose anaplerosis
Kevin Rattigan • 22 Oct 2022
Genetic heterogeneity in AML: the reasoning behind targeting FLT3 and IDH
Richard Stone • 9 Dec 2017
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.